InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.57
(
0.09%
)
US TECH 100
19,233.20
(
0.10%
)
Dow Jones
39,137.64
(
0.03%
)
Brent Oil
85.14
(
0.79%
)
Bitcoin
62,159.17
(
2.21%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biolover

Send PM Follow Ignore
Followers 12
Posts 1150
Boards Moderated 0
Alias Born 10/17/2010

biolover

Re: ronpopeil post# 49364

Tuesday, 11/08/2011 11:04:52 AM

Tuesday, November 08, 2011 11:04:52 AM

Post# of 97239
yes , you are right.

ASH is the mother of hem-onc conference and it has lot of weight. Interim data is good, very big market potential . recent multimillion dollar parternership of JAK1/2 inhibitors with big pharmas. >50 % institutional ownership, low short interest.

Good speculative play, IMO. Off course , sheffs backing does not hurts.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up